No Data
*ST Zhongji: Report for the first quarter of 2025
*Special Treat Zhongji (000972.SZ) announced its first-quarter performance, with a net loss attributable to the parent company of 7.2557 million yuan.
*Special Treat Zhongji (000972.SZ) released the Q1 2025 report. In the first quarter, the company achieved operating income...
Medium Health: 2024 Annual Report Summary
Medium-Base Health: 2024 Annual Report
Chalkis Health Industry (000972.SZ): Stocks Trade has been subjected to Delisted risk warning and will be suspended for one day on March 31.
Chalkis Health Industry (000972.SZ) announced that the company disclosed the "2024 Annual..." on March 29, 2025.
Chalkis Health Industry (000972.SZ): Net loss of 0.231 billion yuan for the year 2024.
Gelonghui March 28丨Chalkis Health Industry (000972.SZ) announced its 2024 annual report, stating that in 2024, the company achieved revenue of 0.308 billion yuan, a year-on-year decrease of 46.48%; the net income attributable to shareholders of the listed company was -0.231 billion yuan, turning from profit to loss year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -0.308 billion yuan; the basic EPS was -0.2992 yuan.
Why Investors Shouldn't Be Surprised By Chalkis Health Industry Co., Ltd's (SZSE:000972) P/S
